Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8429678 | Biology of Blood and Marrow Transplantation | 2018 | 54 Pages |
Abstract
- Microbiome alterations are associated with infection, GVHD, and other adverse transplant outcomes.
- “Multiomic” technologies may better identify clinically actionable microbiome biomarkers.
- Functional microbial characterization may improve diagnostic and therapeutic strategies.
- Knowledge gaps persist in chronic GVHD and extraintestinal microbiome-host interactions.
- Multi-institutional studies and data collection expansion will maximize microbiome research impact.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Tessa M. Andermann, Jonathan U. Peled, Christine Ho, Pavan Reddy, Marcie Riches, Rainer Storb, Takanori Teshima, Marcel R.M. van den Brink, Amin Alousi, Sophia Balderman, Patrizia Chiusolo, William B. Clark, Ernst Holler, Alan Howard, Leslie S. Kean,